Kairos Pharma, Ltd.
KAPA · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $24 | $12 | $15 | $21 |
| - Cash | $6 | $3 | $4 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $18 | $9 | $11 | $20 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.07 | -0.083 | -0.08 | -0.071 |
| % Growth | 15.3% | -3.9% | -11.5% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$2 |
| Capital Expenditures | $1 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$1 | -$1 | -$2 |